Federated Hermes, Inc. Verona Pharma PLC Transaction History
Federated Hermes, Inc.
- $43 Billion
- Q4 2024
A detailed history of Federated Hermes, Inc. transactions in Verona Pharma PLC stock. As of the latest transaction made, Federated Hermes, Inc. holds 1,825,293 shares of VRNA stock, worth $123 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
1,825,293
Previous 2,167,900
15.8%
Holding current value
$123 Million
Previous $62.4 Million
35.91%
% of portfolio
0.2%
Previous 0.14%
Shares
7 transactions
Others Institutions Holding VRNA
# of Institutions
218Shares Held
70.5MCall Options Held
1.4MPut Options Held
299K-
Perceptive Advisors LLC New York, NY6.39MShares$429 Million9.9% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$375 Million18.53% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$227 Million9.42% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.13MShares$210 Million2.79% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.13MShares$210 Million2.81% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $4.09B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...